These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 1107254)
21. Adjuvant combination immunotherapy (BCG and levamisole) in malignant melanoma. Dandapat MC; Mohapatra SK; Patra SK Indian J Cancer; 1985 Jun; 22(2):100-7. PubMed ID: 3842124 [No Abstract] [Full Text] [Related]
22. [Experience with adjuvant chemoimmunotherapy with DTIC and BCG in malignant melanoma (author's transl)]. Pullmann H; Muth M Z Hautkr; 1982 Feb; 57(4):294-7. PubMed ID: 7080583 [No Abstract] [Full Text] [Related]
23. [Use of immunotherapy in the treatment of malignant melanoma of the skin]. Kristensen E Ugeskr Laeger; 1976 Feb; 138(8):468-73. PubMed ID: 1258215 [No Abstract] [Full Text] [Related]
24. [Intranodular treatment with BCG of cutaneous and subcutaneous metastases of malignant melanoma (author's transl)]. Balzarini GP; Cascinelli N; Fontana V; Veronesi U Tumori; 1974; 60(4):345-52. PubMed ID: 4439501 [No Abstract] [Full Text] [Related]
25. [Immunotherapy of malignant melanoma]. Adler A Harefuah; 1986 Jul; 111(1-2):11-7. PubMed ID: 3781371 [No Abstract] [Full Text] [Related]
26. [Intralesion BCG vaccine therapy in cutaneous melanoma metastasis]. Wolf M; Menzel W Dermatol Monatsschr; 1978 Sep; 164(9):671-2. PubMed ID: 710658 [No Abstract] [Full Text] [Related]
27. Intralesional BCG, intravenous immune lymphocytes, and immunization with neuraminidase-treated tumor cells to manage melanoma; A clinical assessment. Seigler HF; Shingleton WW; Pickrell KL Plast Reconstr Surg; 1975 Mar; 55(3):294-8. PubMed ID: 1118487 [TBL] [Abstract][Full Text] [Related]
28. [Combined immunotherapy and cytostatic therapy in stage II and III malignant melanoma (proceedings)]. Rundenstam CM Lakartidningen; 1978 Dec; 75(49):4568-9. PubMed ID: 723339 [No Abstract] [Full Text] [Related]
29. In vitro assay of cell-mediated immunity in BCG therapy of malignant melanoma: a preliminary report. Nathanson L; Clark DA Natl Cancer Inst Monogr; 1973 Dec; 39():221-4. PubMed ID: 4595321 [No Abstract] [Full Text] [Related]
30. Immunological changes in cancer patients receiving BCG. Cochran AJ; Mackie RM; Jackson AM; Ogg LJ; Ross CE Dev Biol Stand; 1977 Apr 13-15; 38():441-8. PubMed ID: 608535 [TBL] [Abstract][Full Text] [Related]
31. BCG stimulation of immune responsiveness in patients with malignant melanoma. Preliminary report. Gutterman J; Mavligit G; McBride C; Frei E; Hersh EM Cancer; 1973 Aug; 32(2):321-7. PubMed ID: 4722915 [No Abstract] [Full Text] [Related]